Current advances in ACE inhibition 3 : proceedings of an International Symposium RAI Congress Centre, Amsterdam, The Netherlands, 19-23 March, 1993
Author(s)
Bibliographic Information
Current advances in ACE inhibition 3 : proceedings of an International Symposium RAI Congress Centre, Amsterdam, The Netherlands, 19-23 March, 1993
Churchill Livingstone, 1993
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
Contains the proceedings of the Third International Symposium on ACE Inhibition (Amsterdam 19-23 March 1993). This book represents an update on issues relating to ACE inhibition. It also provides information relating to current research and developments in the field.
Table of Contents
- THE VASCULATURE: Hypertensive vascular disease - pathophysiological mechanisms
- The role of angiotensin II and other growth factors in vascular hypertrophy
- Vascular remodelling: a role for ACE inhibitors?. THE HEART: From hypertension to hypertrophy - molecular and cellular mechanisms
- The renin-angiotensin system, the heart and the genesis of arrhythmias
- What is the mechanism by which ACE inhibitors reduce mortality in heart failure?
- Left ventrical structural remodelling - potential for therapeutic intervention
- Is the ACE insertion/deletion polymorphism a risk factor for myocardial infarction? THE KIDNEY: Intrarenal actions of angiotensin II: role in health and disease
- Inhibition of renin-angiotensin system and its effects on renal function - experimental evidence
- Do ACE inhibitors preserve renal function in man?
- The role of ACE inhibitors in patients with renal disease
- Renovascular hypertension - the role of ACE inhibitors. CLINICAL PHARMACOLOGY: Differences between ACE inhibitors - are any of clinical relevance?
- ACE inhibitors - concentration effect, dose response and duration of action in man
- Indications for ACE inhibitors in the treatment of hypertension. OTHER INHIBITORS OF THE RENIN SYSTEM: Molecular and regulatory aspects of ACE - new developments
- Localisation of angiotensin II receptors in various tissues
- Differences between angiotensin II antagonists
- Clinical evaluation of AII antagonists in hypertension
- Renin inhibitors
- Renin-angiotensin system inhibition: which intervention site should be targeted?. GENERAL: Diabetes - long-term renal protection - specific benefits from ACE inhibitors
- Long-term renal protection - specific benefits from ACE inhibitors - the case for and against
- Future use of ACE inhibitors.
by "Nielsen BookData"